It doesnt happen to everyone, but early studies suggest the medication can affect libido
For a medication that affects blood sugar and appetite regulation , this uncertainty creates genuine risk
Pre-Approval Clinical Trial Data The clinical trials that led to FDA approval showed: High rates of nausea, vomiting, and abdominal pain among participants Documented cases of severe gastrointestinal issues requiring medical treatment Evidence that slowed gastric emptying persisted in some patients Reports of adverse event reports related to digestive system paralysis Despite this significant evidence from clinical trials, Novo Nordisks labeling focused on common, temporary side effects while failing to warn patients about the risk of permanent gastroparesis
FDA is aware that compounders provide semaglutide in various concentrations
With physician-supervised care, GLP-1 treatment options , and convenient Orange County locations, the clinic provides a setting where patients can begin with more direction and continue with ongoing support